- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
Global Health
Market Cap: AU$5.3m
Provides digital health solutions for the healthcare industry in Australia.
GLH
AU$0.079
7D
-14.1%
1Y
-21.0%
CNS Pharmaceuticals
Market Cap: US$3.4m
A clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors.
CNSP
US$1.26
7D
12.5%
1Y
-99.8%
Biodexa Pharmaceuticals
Market Cap: US$3.4m
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.
BDRX
US$1.30
7D
-7.8%
1Y
-95.8%
Eyenovia
Market Cap: US$3.3m
An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.
EYEN
US$1.13
7D
1.8%
1Y
-98.3%
60 Degrees Pharmaceuticals
Market Cap: US$3.3m
A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.
SXTP
US$2.15
7D
-4.9%
1Y
-83.9%
RedHill Biopharma
Market Cap: US$3.3m
A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.
RDHL
US$1.81
7D
-8.6%
1Y
-85.0%
Lobe Sciences
Market Cap: CA$4.6m
A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.
LOBE
CA$0.025
7D
0%
1Y
25.0%
4Front Ventures
Market Cap: CA$4.6m
Owns and manages licensed cannabis facilities in state-licensed markets in the United States.
FFNT
CA$0.005
7D
0%
1Y
-97.4%
Artelo Biosciences
Market Cap: US$3.3m
A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
ARTL
US$0.94
7D
-6.0%
1Y
-30.9%
VirExit Technologies
Market Cap: US$3.3m
Develops and provides antiviral technologies, personal protective equipment, and health and wellness products.
VXIT
US$0.0007
7D
-6.7%
1Y
-22.2%
Enveric Biosciences
Market Cap: US$3.2m
A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.
ENVB
US$1.26
7D
-0.8%
1Y
-90.7%
Herbal Dispatch
Market Cap: CA$4.5m
Owns and operates cannabis e-commerce platforms in Canada and the United States.
HERB
CA$0.055
7D
0%
1Y
10.0%
AVVAA World Health Care Products
Market Cap: US$3.2m
Provides natural and therapeutic skin care products worldwide.
AVVH
US$0.0033
7D
17.4%
1Y
153.8%
CERo Therapeutics Holdings
Market Cap: US$3.1m
An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
CERO
US$0.58
7D
-10.2%
1Y
-99.5%
Endexx
Market Cap: US$3.1m
Engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market.
EDXC
US$0.0055
7D
-12.7%
1Y
-72.5%
Longevity Health Holdings
Market Cap: US$3.1m
A bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products.
XAGE
US$3.09
7D
-33.7%
1Y
-95.5%
Windtree Therapeutics
Market Cap: US$3.1m
A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.
WINT
US$0.83
7D
-2.2%
1Y
-99.6%
Roquefort Therapeutics
Market Cap: UK£2.3m
A material biotech company, engages in the development of medicines for the treatment of cancer.
ROQ
UK£0.015
7D
-11.8%
1Y
-64.7%
Ethema Health
Market Cap: US$3.1m
Operates behavioral healthcare space specifically in the treatment of substance use disorders.
GRST
US$0.0004
7D
33.3%
1Y
14.3%
Actavia Life Sciences
Market Cap: US$3.1m
A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.
RASP
US$0.004
7D
0%
1Y
-48.1%
Synaptogenix
Market Cap: US$3.1m
Operates as a biopharmaceutical company.
SNPX
US$2.22
7D
-7.9%
1Y
-53.3%
AquaBounty Technologies
Market Cap: US$3.1m
Operates as a land-based aquaculture company in the United States.
AQB
US$0.77
7D
11.5%
1Y
-61.6%
Oxford Cannabinoid Technologies Holdings
Market Cap: US$3.0m
A pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines.
OCTH.F
US$0.0028
7D
0%
1Y
n/a
ASEP Medical Holdings
Market Cap: CA$4.2m
Focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis.
ASEP
CA$0.50
7D
0%
1Y
-75.0%
Ensysce Biosciences
Market Cap: US$3.0m
A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
ENSC
US$2.14
7D
-1.4%
1Y
-77.1%
Palisade Bio
Market Cap: US$3.0m
A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.
PALI
US$0.68
7D
-9.9%
1Y
-89.3%
ALR Technologies SG
Market Cap: US$3.0m
A data management company, provides diabetes care management solutions for human and animal health diabetes.
ALRT.F
US$0.005
7D
66.7%
1Y
-75.0%
Tharimmune
Market Cap: US$3.0m
A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.
THAR
US$1.33
7D
-11.1%
1Y
-76.0%
iSpecimen
Market Cap: US$2.9m
Operates marketplace that provides biospecimens to life science researchers worldwide.
ISPC
US$1.17
7D
2.6%
1Y
-76.7%
NanoVibronix
Market Cap: US$2.9m
Through its subsidiaries, focuses on non-invasive biological response-activating devices that target wound healing and pain therapy and can be administered at home, without the assistance of medical professionals.
NAOV
US$1.43
7D
-65.6%
1Y
-82.0%
Aoxing Pharmaceutical Company
Market Cap: US$2.9m
A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.
AOXG
US$0.0076
7D
15.2%
1Y
5.6%
Galmed Pharmaceuticals
Market Cap: US$2.8m
A biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases.
GLMD
US$1.26
7D
0.8%
1Y
-73.7%
Revelation Biosciences
Market Cap: US$2.8m
Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.
REVB
US$3.03
7D
-2.1%
1Y
-89.8%
BioTech Medics
Market Cap: US$2.8m
Operates as a medical-based holding company.
BMCS
US$0.014
7D
0%
1Y
-26.3%
Alzamend Neuro
Market Cap: US$2.8m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$3.29
7D
-32.3%
1Y
-94.4%
9 Meters Biopharma
Market Cap: US$2.8m
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America.
NMTR
US$0.20
7D
-71.1%
1Y
-96.0%